Der LAI-Test und sein diagnostischer Wert bei bösartigen Tumoren
Reference7 articles.
1. Ayeni AO, Thomson DMP, MacFarlane JK, Daly D (1981) A comparison of the tube leukocyte inhibition assay and standard physical methods for diagosing colorectal cancer. Cancer 48: 1855–1862
2. Fujisawa T, Waldman StR Yonemoto R (1977) Leukocyte adherence inhibition by soluble tumor antigens in breast cancer patients. Cancer 39: 506–513
3. Halliday WJ, Miller S (1972) Leukocyte adherence inhibition: a simple test for cellmediated immunity and serum blocking factors. Int J Cancer 9: 477–483
4. MacFarlane JK, Thomson DMP, Phelan K, Shenouda G, Scanzano R (1982) Predictive value of tube leukocyte adherence inhibition ( LAI) assay for breast, colorectal, stomach and pancreatic cancer. Cancer 49: 1185–1193
5. Morizane T, Sjögren HO (1983) A leukocyte adherence inhibition ( LAI) assay of antitumor immunity in rats using selective radioimmunological assessment of adherence of T- lymphocytes and monocytes. Int J Cancer 31: 803–812